For those familiar with fintech and Silicon Valley, Jeff Brown is a known name. In one of his latest presentations, Brown is interviewed by Chris Hurt, with only a handful of spectators and interactive guests in attendance, talking about three ground-breaking “tech lag stocks” that can potentially turn any smart investor into a millionaire, in just a few years.
He talks about how most investors invest in tech stocks with a “lag” of months, if not years, meaning they find out too late about the latest innovations, such as precision medicine, robotics, and 6G, after large investment funds and private investors have already bid up the stock price of promising new companies. As a result, most small investors only get “scraps” or very small profits (if any) out of stocks because they begin to lose momentum by the time the average retail investor gets ahold of them.
To find out the name and ticker symbol of the companies he’s teasing, you have to join Brown’s investment newsletter program: The Near Future Report, for $49 per year. Included, you will receive 12 monthly issues of the report, US-based customer service, three special free reports, and access to The Near Future Report research library, all backed by a 60-day money-back guarantee. For those who are just interested in the names of the companies being teased, keep reading to see what we were able to uncover, for free.
According to his official bio, Jeff Brown is a former tech executive for high-profile companies like Qualcomm and NXP Semiconductors. He has devoted most of his life to technology and has been an active investor for over three decades. He holds professional certificates from Stanford and MIT and he’s also an alumnus of the Yale School of Management. He also describes himself as “an angel investor with stakes in dozens of promising startups”.
The Tech Lag Opportunity
The interview of Jeff Brown is nothing more than an in-depth primer on various emerging sectors in which investors should consider allocating their money into, if they want to earn above average profits. His entire pitch is based on the so-called “tech lag” or the amount of time most private investors have to wait before they find out about promising new investment opportunities. During this lag, big banks, Wall Street, and other institutions have enough time to amass stakes worth hundreds of millions, while most people will only collect “scraps”, if any profits after they have bid up the stocks favored by the “too big to fail” institutional investors.
To prevent this tech lag, Brown is willing to use all his inside information and investing pedigree to share the three most sought-after tech sectors people should keep an eye on in the years ahead. Throughout the presentation, the author teases a series of different investment opportunities in sectors like precision medicine, robotics, and even “an early version of 6G”.
The Precision Medicine, Robotics & 6G Companies Being Teased
Brown’s presentation is dense, consisting of several points that could be interesting for investors looking for new business opportunities. The author started by mentioning this “tech lag” which people can actually avoid if they have access to an analyst or investment manager from inside the top institutions that also has experience in finding and picking the best stocks in their field.
Brown proports to be this insider, saying “The tech lag destroys your chance to profit from technology stocks. And there’s one way to beat it…” by suggesting three technologies “you’ve likely never heard of”. “They might sound like science fiction, but I assure you… These technologies are real and approaching major, mainstream breakthroughs”.
Brown also talks about biotech and we have seen the impact of some of these companies during the latest coronavirus pandemic. Big biotech companies like Moderna, BioNTech, and others have surged, bringing great profits for those who invested in their stocks more than a year ago.
The first tech the author mentions “goes far beyond biotech. We’ll no longer need their expensive cocktails of imprecise drugs… many of them with drastic side effects.” “This is about preventing disease altogether”, “through something called precision medicine.”
According to Brown, precision medicine “allows doctors to identify faulty DNA ahead of time”, “removing the threat of disease”. He is positive that this new type of technology will become more popular in 5-10 years, with companies like Kodiak Sciences or FHAI (Fountain Healthy Aging) blooming.
- One of the main focuses of these precision medicine companies will be “gene therapy”, which, “over the next few years, it’s expected to become a $200 billion industry”.
- Brown already has his eyes on one of these companies, mentioning that it “develops revolutionary gene therapies for rare diseases.”
- According to Brown, “this company could be in the possession of a one-shot-and-one-cure” and that by “using precision medicine, they can essentially identify the faulty gene and insert a new one that works”.
- He continues by saying that “its unique gene therapy is on the verge of FDA approval” and that “this company already has six treatments approved by the FDA” and is also “on track for additional FDA approval as early as 2021”.
Unfortunately, the name and ticker symbol of this stock Brown teases eludes us, but can be found in the report “Precision Insider: The $200 Billion Medical Breakthrough”, part of The Near Future Report newsletter program. It may also have some overlap with this teaser from Jeff Brown that we previously covered right here.
The second technology Brown refers to is robotics, but this is something we have been seeing coming for the past few decades, so it can hardly be acknowledged as “breakthrough” or “disruptive”.
However, Brown claims that “it’s just the type of innovation that will make America competitive again.” “I expect hundreds of thousands of jobs will finally return from overseas”. “I’m calling it the American manufacturing renaissance”.
He expects the global robotics market to top $209 billion in a few years time, generating thousands of new jobs and potentially re-patriating thousands of others back to the US.
- As for the robotics field, Brown talks about two companies, with the first one specializing “in machine vision”. Which is used to spot manufacturing defects on assembly lines, for inventory control in massive warehouses, and perform exact measurements in manufacturing plants. According to the investor, “one company makes the eyes that help robots see”.
The second company teased is a competitor of NXP Semiconductors out of Japan, and Brown claims that “every kind of device needs this company’s technology” and “its tech is used across all sectors, including automotive, wireless communications like 4G and 5G, and industrial.”
The names and ticker symbols of both these companies can be found in Brown’s special report, “Robotics Insider: How to Profit From the Return of American Manufacturing”. There are a few potentially choices here, such as: Texas Instruments (NASDAQ: TXN), Marvell Technology Group (NASDAQ MRVL) or Micron Technology (NASDAQ: MU) as they all compete with NXP Semiconductors and are actively working on machine vision. However, we cannot reliably pinpoint the exact picks.
Lastly, Jeff Brown also briefly mentions 6G technology, detailing it in the report named “6G Insider: The Next Trillion-Dollar Network”. Unfortunately, the “angel investor” doesn’t go into depth about any company in this space, which is his way of getting new subscribers to buy into his newsletter program if you want to know all of the “tech lag” stock picks. However, we have covered a previous teaser of Jeff Brown’s covering 6G, which has many similarities to his new report.
Are The 3 Tech Lag Sectors A Good Investment Opportunity?
All the sectors focused on in this interview – robotics, biotech, and precision medicine will most likely become highly popular in the next decade, dictating many aspects of our lives in a new super-tech era. However, as many companies are now considered pioneers and will still require billions of dollars for R&D, suppressing earnings and cashflow for years.
There is also the fact that emerging or “hot” sectors seldom produce the best performing long-term investments, due to a variety of factors including over-priced valuations, little to no profitability as the businesses require cash flow to be reinvested in order to grow, as well as the hype plain old not living up to the reality given how quickly technology is developing today. For these reasons, we wouldn’t necessarily recommend diving head first into every new, emerging sector that looks promising.
Quick Recap & Conclusion
- In this interview-like presentation, investor Jeff Brown and presenter Chris Hurt talk about some of the latest investment opportunities in high-tech sectors like robotics, precision medicine, and biotechnology.
- Throughout his presentation, Brown mentions several companies from these sectors, that can bring early investors potential profits of over 10,000% in just a few years. Each sector Brown advises people to invest in is covered in one of his three special reports, which are part of The Near Future Report, a newsletter program sold for $49 per year.
- Unfortunately, Brown didn’t provide enough reliable information about any of these companies, so we couldn’t verifiable uncover any of them here. However, we did a little bit of speculating ourselves about some potential picks, such as: Texas Instruments (NASDAQ: TXN), Marvell Technology Group (NASDAQ MRVL) or Micron Technology (NASDAQ: MU)
- Overall, we wouldn’t recommend blindly chasing every new investment fad that comes along, as its a quick way to not only miss out on other opportunities, but also lose your initial capital.
What do you think Brown’s stock picks are? Are you already invested in stocks in any of the sectors that are teased? Let us know your thoughts as always in the comment section below.
I’m getting bombarded with a “pre ipo” investment strategy that had a webinar today which I did not attend. Wyatt is the name, I believe. Also, I’d love to get your thoughts on Motley Fool.
Seems to be hipe on Pre IPO Investment for large gains. Is this another Tease for membership?